Lv2
200 积分 2023-12-13 加入
Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
2天前
已完结
Emerging roles of oxyntomodulin-based glucagon-like peptide-1/glucagon co-agonist analogs in diabetes and obesity
13天前
已完结
Comparative Effects of GLP-1 Agonists, Sleeve Gastrectomy and Roux-en-Y Gastric Bypass on Diabetes Mellitus Outcomes
1个月前
已完结
Time in tight range: A key metric for optimal glucose control in the era of advanced diabetes technologies and therapeutics
1个月前
已完结
Association of Perioperative Glucagon-like Peptide-1 Receptor Agonist Use and Postoperative Outcomes
1个月前
已完结
The promising potential of gene therapy for diabetes mellitus
1个月前
已完结
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
1个月前
已完结
Large language models for diabetes care: Potentials and prospects
1个月前
已完结
Continuous glucose monitoring and intrapersonal variability in fasting glucose
1个月前
已完结
Dapagliflozin as Monotherapy in Drug-Naive Asian Patients With Type 2 Diabetes Mellitus: A Randomized, Blinded, Prospective Phase III Study
2个月前
已关闭
皖公网安备34019202002308
